Healthcare entity
regulation is the sole category represented across all 1 tracked stories. NV-387 is most often covered alongside ACOREP, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. NV-387 appears in 1 tracked Healthcare story from July 13, 2026.
Last mentioned: Jul 13, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. NV-387 is most often covered alongside ACOREP, which appears in 1 of these 1 story. The tracked stories average 3 original sources each. NV-387 appears in 1 tracked Healthcare story from July 13, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 5 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering NV-387. Shared-story counts are live from our verified record — not editorial picks.
Ethics Approval Received
NanoViricides announces National Ethics Committee approval for Phase II trial of NV-387 oral gummies for Ebola.
Outbreak Worsens
DRC public health institute reports 1,926 confirmed Ebola cases and 702 deaths, with spread to Haut-Uele and Tshopo provinces.
As the DRC Ebola outbreak surpasses 1,900 cases with 702 fatalities, NanoViricides’ oral NV-387 gummies gain ethics approval for a Phase II trial. The chewable format could overcome logistical hurdles in resource-limited regions, potentially reshaping epidemic management if proven effective.
NV-387 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
